LGR5 and neoplasm: The research performed by Bauer and collaborators including GC patients treated with neoadjuvant chemotherapy based on platinum compounds or 5-FU, explored LGR5 expression in pre-therapeutic biopsies and resected tumors, finding increased expression of this marker in residual tumor cells in post-therapeutic samples [71].